Stocktoria
Telomir Pharmaceuticals, Inc. TELO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2024-02-09
Telomir Pharmaceuticals, Inc. statistics & valuation
Market cap$85.3M
P / B14.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Return on assets | -141.8% | -1248.7% | -273.8% | -1752.8% |
| Return on equity | -176.1% | -2571.0% | -380.2% | 91.1% |
| Current ratio | 5.14 | 1.94 | 0.33 | 0.05 |
Source: SEC EDGAR filings · CIK 0001971532 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.